25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

SAVA (Cassava Sciences Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze Cassava Sciences Inc together

I guess you are interested in Cassava Sciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Cassava Sciences Inc’s Financial Insights
  • 📈 Technical Analysis (TA) – Cassava Sciences Inc’s Price Targets

I'm going to help you getting a better view of Cassava Sciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Cassava Sciences Inc

I send you an email if I find something interesting about Cassava Sciences Inc.

1. Quick Overview

1.1. Quick analysis of Cassava Sciences Inc (30 sec.)










1.2. What can you expect buying and holding a share of Cassava Sciences Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$2.64
Expected worth in 1 year
$3.66
How sure are you?
20.0%

+ What do you gain per year?

Total Gains per Share
$1.01
Return On Investment
47.6%

For what price can you sell your share?

Current Price per Share
$2.13
Expected price per share
$1.45 - $2.27
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Cassava Sciences Inc (5 min.)




Live pricePrice per Share (EOD)
$2.13
Intrinsic Value Per Share
$-16.76 - $7.79
Total Value Per Share
$-14.11 - $10.43

2.2. Growth of Cassava Sciences Inc (5 min.)




Is Cassava Sciences Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$127.6m$137.6m$19.6m12.5%

How much money is Cassava Sciences Inc making?

Current yearPrevious yearGrowGrow %
Making money-$18.1m-$11.9m-$6.2m-34.2%
Net Profit Margin0.0%-222.7%--

How much money comes from the company's main activities?

2.3. Financial Health of Cassava Sciences Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#307 / 872

Most Revenue
#696 / 872

Most Profit
#624 / 872

Most Efficient
#237 / 872
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Cassava Sciences Inc?

Welcome investor! Cassava Sciences Inc's management wants to use your money to grow the business. In return you get a share of Cassava Sciences Inc.

First you should know what it really means to hold a share of Cassava Sciences Inc. And how you can make/lose money.

Speculation

The Price per Share of Cassava Sciences Inc is $2.13. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Cassava Sciences Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Cassava Sciences Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $2.64. Based on the TTM, the Book Value Change Per Share is $0.25 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.65 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Cassava Sciences Inc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.48-22.7%-0.38-17.7%-0.25-11.6%-0.35-16.5%-0.27-12.6%-0.16-7.5%
Usd Book Value Change Per Share-0.37-17.6%0.2511.9%-0.65-30.5%-0.19-8.9%0.115.0%0.052.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.37-17.6%0.2511.9%-0.65-30.5%-0.19-8.9%0.115.0%0.052.2%
Usd Price Per Share1.50-11.41-20.99-21.10-27.40-14.91-
Price to Earnings Ratio-0.77-2.43--5.57--7.14--37.18--26.01-
Price-to-Total Gains Ratio-4.01--16.93--39.87--33.54--236.28--124.64-
Price to Book Ratio0.57-3.26-8.04-6.13-7.81-7.76-
Price-to-Total Gains Ratio-4.01--16.93--39.87--33.54--236.28--124.64-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.13
Number of shares469
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.250.11
Usd Total Gains Per Share0.250.11
Gains per Quarter (469 shares)118.9849.89
Gains per Year (469 shares)475.90199.58
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
104764660200190
209529420399390
30142814180599590
40190418940798790
50238023700998990
6028552846011971190
7033313322013971390
8038073798015971590
9042834274017961790
10047594750019961990

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%2.010.00.016.7%2.018.00.010.0%2.038.00.05.0%13.088.00.012.9%
Book Value Change Per Share1.03.00.025.0%2.010.00.016.7%4.016.00.020.0%8.032.00.020.0%38.063.00.037.6%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%2.00.099.02.0%
Total Gains per Share1.03.00.025.0%2.010.00.016.7%4.016.00.020.0%8.032.00.020.0%40.061.00.039.6%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Cassava Sciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.3740.254-248%-0.649+73%-0.189-50%0.106-452%0.046-911%
Book Value Per Share--2.6423.255-19%2.849-7%3.499-24%3.607-27%2.008+32%
Current Ratio--9.0777.079+28%7.312+24%12.247-26%24.881-64%21.141-57%
Debt To Asset Ratio--0.0940.162-42%0.195-52%0.134-29%0.093+1%0.080+17%
Debt To Equity Ratio--0.1040.204-49%0.324-68%0.192-46%0.128-19%0.101+3%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--176473850.000667522639.000-74%1121349821.000-84%1153978606.667-85%1471690278.400-88%804014929.125-78%
Eps---0.484-0.377-22%-0.248-49%-0.351-27%-0.268-45%-0.160-67%
Ev To Ebitda Ratio---1.811-4.728+161%-11.651+543%-11.977+561%-42.890+2269%-29.843+1548%
Free Cash Flow Per Share---0.235-0.565+141%-0.455+94%-0.461+96%-0.360+53%-0.199-15%
Free Cash Flow To Equity Per Share---0.233-0.035-85%-0.328+41%-0.159-32%-0.105-55%-0.053-77%
Gross Profit Margin--1.0000.777+29%1.0010%0.926+8%0.999+0%1.000+0%
Intrinsic Value_10Y_max--7.790----------
Intrinsic Value_10Y_min---16.756----------
Intrinsic Value_1Y_max---0.569----------
Intrinsic Value_1Y_min---1.827----------
Intrinsic Value_3Y_max---0.681----------
Intrinsic Value_3Y_min---5.393----------
Intrinsic Value_5Y_max--0.447----------
Intrinsic Value_5Y_min---8.828----------
Market Cap102895827.000+30%72461850.000551193139.000-87%1013982821.000-93%1019296690.000-93%1323443228.400-95%720210404.125-90%
Net Profit Margin----0%-2.2270%801.619-100%4023.971-100%1844.438-100%
Operating Margin----0%-2.4260%968.497-100%4192.098-100%1908.789-100%
Operating Ratio----0%2.426-100%-986.5060%-4281.1540%-1953.3050%
Pb Ratio0.806+30%0.5683.260-83%8.042-93%6.131-91%7.812-93%7.762-93%
Pe Ratio-1.099-42%-0.7742.426-132%-5.568+619%-7.143+823%-37.183+4704%-26.006+3260%
Price Per Share2.130+30%1.50011.410-87%20.990-93%21.100-93%27.396-95%14.909-90%
Price To Free Cash Flow Ratio-2.269-42%-1.598-7.409+364%-11.852+642%-13.723+759%-43.239+2606%-32.812+1953%
Price To Total Gains Ratio-5.689-42%-4.006-16.925+322%-39.871+895%-33.545+737%-236.280+5798%-124.635+3011%
Quick Ratio--8.9296.624+35%6.990+28%11.669-23%24.237-63%20.895-57%
Return On Assets---0.166-0.110-34%-0.065-61%-0.087-47%-0.068-59%-0.100-40%
Return On Equity---0.183-0.127-31%-0.036-80%-0.085-54%-0.067-63%-0.105-43%
Total Gains Per Share---0.3740.254-248%-0.649+73%-0.189-50%0.106-452%0.046-911%
Usd Book Value--127616000.000157233250.000-19%137633250.000-7%169008250.000-24%174234850.000-27%97013800.000+32%
Usd Book Value Change Per Share---0.3740.254-248%-0.649+73%-0.189-50%0.106-452%0.046-911%
Usd Book Value Per Share--2.6423.255-19%2.849-7%3.499-24%3.607-27%2.008+32%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--176473850.000667522639.000-74%1121349821.000-84%1153978606.667-85%1471690278.400-88%804014929.125-78%
Usd Eps---0.484-0.377-22%-0.248-49%-0.351-27%-0.268-45%-0.160-67%
Usd Free Cash Flow---11336000.000-27310250.000+141%-21988500.000+94%-22256500.000+96%-17398850.000+53%-9616351.900-15%
Usd Free Cash Flow Per Share---0.235-0.565+141%-0.455+94%-0.461+96%-0.360+53%-0.199-15%
Usd Free Cash Flow To Equity Per Share---0.233-0.035-85%-0.328+41%-0.159-32%-0.105-55%-0.053-77%
Usd Market Cap102895827.000+30%72461850.000551193139.000-87%1013982821.000-93%1019296690.000-93%1323443228.400-95%720210404.125-90%
Usd Price Per Share2.130+30%1.50011.410-87%20.990-93%21.100-93%27.396-95%14.909-90%
Usd Profit---23403000.000-18197000.000-22%-11975750.000-49%-16437916.667-30%-12602850.000-46%-7567925.000-68%
Usd Revenue----0%587000.000-100%195516.667-100%117300.000-100%58652.600-100%
Usd Total Gains Per Share---0.3740.254-248%-0.649+73%-0.189-50%0.106-452%0.046-911%
 EOD+5 -3MRQTTM+13 -20YOY+18 -173Y+10 -265Y+9 -2710Y+8 -28

3.3 Fundamental Score

Let's check the fundamental score of Cassava Sciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.099
Price to Book Ratio (EOD)Between0-10.806
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than18.929
Current Ratio (MRQ)Greater than19.077
Debt to Asset Ratio (MRQ)Less than10.094
Debt to Equity Ratio (MRQ)Less than10.104
Return on Equity (MRQ)Greater than0.15-0.183
Return on Assets (MRQ)Greater than0.05-0.166
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Cassava Sciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5057.564
Ma 20Greater thanMa 501.989
Ma 50Greater thanMa 1001.969
Ma 100Greater thanMa 2002.016
OpenGreater thanClose2.150
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Cassava Sciences Inc

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. Cassava Sciences, Inc. was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. The company was incorporated in 1998 and is based in Austin, Texas.

Fundamental data was last updated by Penke on 2025-06-20 15:31:06.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Cassava Sciences Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Cassava Sciences Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Cassava Sciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-222.7%+222.7%
TTM-5Y402,397.1%-402,397.1%
5Y402,397.1%10Y184,443.8%+217,953.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--93.6%+93.6%
TTM--140.9%+140.9%
YOY-222.7%-197.6%-25.1%
3Y80,161.9%-248.5%+80,410.4%
5Y402,397.1%-343.4%+402,740.5%
10Y184,443.8%-496.2%+184,940.0%
4.3.1.2. Return on Assets

Shows how efficient Cassava Sciences Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Cassava Sciences Inc to the Biotechnology industry mean.
  • -16.6% Return on Assets means that Cassava Sciences Inc generated $-0.17 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Cassava Sciences Inc:

  • The MRQ is -16.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -11.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-16.6%TTM-11.0%-5.6%
TTM-11.0%YOY-6.5%-4.5%
TTM-11.0%5Y-6.8%-4.2%
5Y-6.8%10Y-10.0%+3.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-16.6%-11.6%-5.0%
TTM-11.0%-11.6%+0.6%
YOY-6.5%-11.4%+4.9%
3Y-8.7%-11.8%+3.1%
5Y-6.8%-12.0%+5.2%
10Y-10.0%-13.7%+3.7%
4.3.1.3. Return on Equity

Shows how efficient Cassava Sciences Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Cassava Sciences Inc to the Biotechnology industry mean.
  • -18.3% Return on Equity means Cassava Sciences Inc generated $-0.18 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Cassava Sciences Inc:

  • The MRQ is -18.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -12.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-18.3%TTM-12.7%-5.6%
TTM-12.7%YOY-3.6%-9.0%
TTM-12.7%5Y-6.7%-6.0%
5Y-6.7%10Y-10.5%+3.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-18.3%-13.5%-4.8%
TTM-12.7%-14.9%+2.2%
YOY-3.6%-14.6%+11.0%
3Y-8.5%-16.8%+8.3%
5Y-6.7%-17.5%+10.8%
10Y-10.5%-19.9%+9.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Cassava Sciences Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Cassava Sciences Inc is operating .

  • Measures how much profit Cassava Sciences Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Cassava Sciences Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Cassava Sciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-242.6%+242.6%
TTM-5Y419,209.8%-419,209.8%
5Y419,209.8%10Y190,878.9%+228,330.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--232.5%+232.5%
TTM--250.5%+250.5%
YOY-242.6%-209.2%-33.4%
3Y96,849.7%-234.1%+97,083.8%
5Y419,209.8%-346.1%+419,555.9%
10Y190,878.9%-477.5%+191,356.4%
4.3.2.2. Operating Ratio

Measures how efficient Cassava Sciences Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Cassava Sciences Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY2.426-2.426
TTM-5Y-4,281.154+4,281.154
5Y-4,281.15410Y-1,953.305-2,327.849
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.111-2.111
TTM-2.694-2.694
YOY2.4263.096-0.670
3Y-986.5063.652-990.158
5Y-4,281.1544.745-4,285.899
10Y-1,953.3056.614-1,959.919
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Cassava Sciences Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Cassava Sciences Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 9.08 means the company has $9.08 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Cassava Sciences Inc:

  • The MRQ is 9.077. The company is very able to pay all its short-term debts. +2
  • The TTM is 7.079. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ9.077TTM7.079+1.998
TTM7.079YOY7.312-0.233
TTM7.0795Y24.881-17.801
5Y24.88110Y21.141+3.740
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.0773.661+5.416
TTM7.0793.846+3.233
YOY7.3124.140+3.172
3Y12.2474.688+7.559
5Y24.8815.746+19.135
10Y21.1416.147+14.994
4.4.3.2. Quick Ratio

Measures if Cassava Sciences Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Cassava Sciences Inc to the Biotechnology industry mean.
  • A Quick Ratio of 8.93 means the company can pay off $8.93 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Cassava Sciences Inc:

  • The MRQ is 8.929. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 6.624. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ8.929TTM6.624+2.305
TTM6.624YOY6.990-0.366
TTM6.6245Y24.237-17.613
5Y24.23710Y20.895+3.342
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.9292.848+6.081
TTM6.6243.169+3.455
YOY6.9903.786+3.204
3Y11.6694.311+7.358
5Y24.2375.703+18.534
10Y20.8956.368+14.527
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Cassava Sciences Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Cassava Sciences Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Cassava Sciences Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.09 means that Cassava Sciences Inc assets are financed with 9.4% credit (debt) and the remaining percentage (100% - 9.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Cassava Sciences Inc:

  • The MRQ is 0.094. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.162. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.094TTM0.162-0.068
TTM0.162YOY0.195-0.033
TTM0.1625Y0.093+0.069
5Y0.09310Y0.080+0.013
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0940.329-0.235
TTM0.1620.349-0.187
YOY0.1950.331-0.136
3Y0.1340.340-0.206
5Y0.0930.349-0.256
10Y0.0800.379-0.299
4.5.4.2. Debt to Equity Ratio

Measures if Cassava Sciences Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Cassava Sciences Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 10.4% means that company has $0.10 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Cassava Sciences Inc:

  • The MRQ is 0.104. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.204. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.104TTM0.204-0.100
TTM0.204YOY0.324-0.120
TTM0.2045Y0.128+0.076
5Y0.12810Y0.101+0.027
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1040.379-0.275
TTM0.2040.437-0.233
YOY0.3240.414-0.090
3Y0.1920.450-0.258
5Y0.1280.464-0.336
10Y0.1010.515-0.414
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Cassava Sciences Inc generates.

  • Above 15 is considered overpriced but always compare Cassava Sciences Inc to the Biotechnology industry mean.
  • A PE ratio of -0.77 means the investor is paying $-0.77 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Cassava Sciences Inc:

  • The EOD is -1.099. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.774. Based on the earnings, the company is expensive. -2
  • The TTM is 2.426. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD-1.099MRQ-0.774-0.325
MRQ-0.774TTM2.426-3.201
TTM2.426YOY-5.568+7.995
TTM2.4265Y-37.183+39.610
5Y-37.18310Y-26.006-11.177
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.099-2.356+1.257
MRQ-0.774-2.077+1.303
TTM2.426-2.574+5.000
YOY-5.568-3.760-1.808
3Y-7.143-3.773-3.370
5Y-37.183-6.193-30.990
10Y-26.006-6.876-19.130
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Cassava Sciences Inc:

  • The EOD is -2.269. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.598. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -7.409. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.269MRQ-1.598-0.671
MRQ-1.598TTM-7.409+5.811
TTM-7.409YOY-11.852+4.443
TTM-7.4095Y-43.239+35.830
5Y-43.23910Y-32.812-10.427
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.269-3.246+0.977
MRQ-1.598-2.705+1.107
TTM-7.409-3.704-3.705
YOY-11.852-4.402-7.450
3Y-13.723-5.070-8.653
5Y-43.239-8.477-34.762
10Y-32.812-9.305-23.507
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Cassava Sciences Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.57 means the investor is paying $0.57 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Cassava Sciences Inc:

  • The EOD is 0.806. Based on the equity, the company is cheap. +2
  • The MRQ is 0.568. Based on the equity, the company is cheap. +2
  • The TTM is 3.260. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD0.806MRQ0.568+0.238
MRQ0.568TTM3.260-2.692
TTM3.260YOY8.042-4.782
TTM3.2605Y7.812-4.552
5Y7.81210Y7.762+0.050
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.8062.038-1.232
MRQ0.5681.843-1.275
TTM3.2602.125+1.135
YOY8.0422.442+5.600
3Y6.1312.492+3.639
5Y7.8123.652+4.160
10Y7.7624.311+3.451
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Cassava Sciences Inc.

4.8.1. Institutions holding Cassava Sciences Inc

Institutions are holding 33.06% of the shares of Cassava Sciences Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31BlackRock Inc7.19340.00013474980-265163-7.0896
2025-03-31Vanguard Group Inc5.05570.00012442307-71178-2.8318
2025-03-31Geode Capital Management, LLC2.12510.00011026599196041.9468
2024-12-31UBS Group AG1.92670.0004930726841853947.2539
2025-03-31Two Sigma Advisers, LLC1.88090.003190860030190049.761
2025-03-31State Street Corp1.80910.0001873946-122716-12.3127
2025-03-31JPMorgan Chase & Co1.63540.000179001638868196.847
2025-03-31Susquehanna International Group, LLP1.14270.000155202127162896.874
2025-03-31Goldman Sachs Group Inc1.02740.000149631321740477.948
2025-03-31GMT Capital Corp0.93170.03584501004501000
2025-03-31Two Sigma Investments LLC0.89550.0014432581-129501-23.0395
2025-03-31Morgan Stanley - Brokerage Accounts0.7791037635011016041.384
2025-03-31Northern Trust Corp0.7640.0001369090-37472-9.2168
2025-03-31Charles Schwab Investment Management Inc0.74780.00013612534151112.9827
2025-03-31Jane Street Group LLC0.57310.0001276835-123404-30.8326
2025-03-31TANG CAPITAL MANAGEMENT LLC0.4140.01662000002000000
2024-12-31Nuveen Asset Management, LLC0.34260.0001165514-10321-5.8697
2025-03-31Verition Fund Managegment, LLC0.27980.0009135166-11770-8.0103
2025-03-31STRS OHIO0.24610.0008118900-44100-27.0552
2025-03-31Bank of America Corp0.24180116820-362408-75.6233
Total 30.01190.060114498117+1664808+11.5%

4.9.2. Funds holding Cassava Sciences Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-04-30Vanguard Total Stock Mkt Idx Inv2.65690.0001128351100
2025-05-31iShares Russell 2000 ETF2.08430.0033100687800
2025-04-30Vanguard Institutional Extnd Mkt Idx Tr1.40750.00167992000
2025-03-31Fidelity Small Cap Index0.84720.0025409244-6102-1.4691
2025-05-31iShares Russell 2000 Growth ETF0.72560.006435051600
2025-05-31State St Russell Sm/Mid Cp® Indx SL Cl I0.54390.001326276500
2025-04-30Fidelity Extended Market Index0.51690.0011249721-2387-0.9468
2025-05-31Schwab US Small-Cap ETF™0.44420.0026214569-555-0.258
2025-04-30Vanguard Russell 2000 ETF0.41830.0027202052111865.8607
2025-05-31State St Russell Sm Cap® Indx SL Cl I0.29520.003314262000
2025-04-30Vanguard Health Care ETF0.29490.0012142456-1269-0.8829
2025-03-31NT R2000 Index Fund - NL0.2120.002610239444584.552
2025-04-30Schwab Small Cap Index0.20150.00269733400
2025-03-31Extended Equity Market Fund K0.1890.001912932800.3076
2025-03-31NT R2000 Index Fund - DC - NL - 30.16930.00268179919022.3806
2025-04-30Fidelity Total Market Index0.16750.00018089300
2025-04-30iShares Russell 2000 Small-Cap Idx Instl0.1550.00297490000
2025-03-31Russell 2500™ Index Fund F0.14140.001168288-15-0.022
2025-04-30Fidelity Series Total Market Index0.13250.00016401123723.8482
2025-04-30SPDR® Russell 2000 US Small Cap ETF0.1270.002761354-5978-8.8784
Total 11.73010.04125666518+3892+0.1%

5.3. Insider Transactions

Insiders are holding 12.787% of the shares of Cassava Sciences Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-11-29Eric SchoenSELL598003.86
2024-11-29James William KupiecSELL40003.87
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets140,932
Total Liabilities13,316
Total Stockholder Equity127,616
 As reported
Total Liabilities 13,316
Total Stockholder Equity+ 127,616
Total Assets = 140,932

Assets

Total Assets140,932
Total Current Assets120,151
Long-term Assets20,781
Total Current Assets
Cash And Cash Equivalents 117,328
Net Receivables 864
Other Current Assets 1,959
Total Current Assets  (as reported)120,151
Total Current Assets  (calculated)120,151
+/-0
Long-term Assets
Property Plant Equipment 20,781
Long-term Assets  (as reported)20,781
Long-term Assets  (calculated)20,781
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities13,237
Long-term Liabilities79
Total Stockholder Equity127,616
Total Current Liabilities
Accounts payable 8,192
Other Current Liabilities 5,045
Total Current Liabilities  (as reported)13,237
Total Current Liabilities  (calculated)13,237
+/-0
Long-term Liabilities
Long-term Liabilities Other 79
Long-term Liabilities  (as reported)79
Long-term Liabilities  (calculated)79
+/-0
Total Stockholder Equity
Common Stock48
Retained Earnings -428,514
Other Stockholders Equity 556,082
Total Stockholder Equity (as reported)127,616
Total Stockholder Equity (calculated)127,616
+/-0
Other
Capital Stock48
Cash and Short Term Investments 117,328
Common Stock Shares Outstanding 48,262
Liabilities and Stockholders Equity 140,932
Net Debt -117,328
Net Invested Capital 127,616
Net Working Capital 106,914
Property Plant and Equipment Gross 24,231



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-31
> Total Assets 
22,865
21,139
82,841
81,147
78,831
74,504
71,470
68,136
64,032
60,640
56,691
53,325
48,028
44,531
86,638
80,513
72,425
62,904
55,802
101,192
92,772
83,190
73,774
215,795
215,778
213,243
218,286
208,456
212,245
208,633
208,810
207,625
192,497
179,122
195,497
193,436
189,733
186,316
182,732
182,005
178,597
182,084
180,794
99,195
101,226
102,593
100,592
98,963
96,810
94,440
93,259
56,859
54,870
53,200
51,756
50,103
47,319
45,391
43,591
40,906
39,635
37,756
35,653
31,918
28,626
24,940
22,482
19,302
17,604
14,269
12,377
10,831
11,058
9,833
20,836
20,139
19,523
18,805
18,375
23,486
25,977
25,498
25,399
94,300
284,050
281,305
274,249
266,782
244,191
227,381
207,286
234,834
218,111
197,248
172,529
151,663
155,718
243,568
223,753
157,533
140,932
140,932157,533223,753243,568155,718151,663172,529197,248218,111234,834207,286227,381244,191266,782274,249281,305284,05094,30025,39925,49825,97723,48618,37518,80519,52320,13920,8369,83311,05810,83112,37714,26917,60419,30222,48224,94028,62631,91835,65337,75639,63540,90643,59145,39147,31950,10351,75653,20054,87056,85993,25994,44096,81098,963100,592102,593101,22699,195180,794182,084178,597182,005182,732186,316189,733193,436195,497179,122192,497207,625208,810208,633212,245208,456218,286213,243215,778215,79573,77483,19092,772101,19255,80262,90472,42580,51386,63844,53148,02853,32556,69160,64064,03268,13671,47074,50478,83181,14782,84121,13922,865
   > Total Current Assets 
22,283
20,073
82,576
79,773
76,585
71,964
68,963
65,714
61,693
58,389
54,530
51,247
46,036
42,625
84,816
78,750
70,540
61,038
53,974
99,656
91,293
81,685
72,087
214,164
214,147
211,693
216,859
207,114
210,254
206,659
206,407
205,374
190,363
177,105
193,598
190,636
187,605
184,255
180,981
178,471
177,714
181,260
180,028
98,484
100,557
101,964
100,084
98,489
96,371
94,037
92,907
56,507
54,518
52,848
51,416
50,103
47,243
45,307
43,510
40,829
39,367
37,502
35,413
31,691
28,413
24,741
22,220
19,070
17,390
14,079
12,204
10,663
10,889
9,699
20,720
20,040
19,265
18,583
18,189
23,349
25,877
25,440
25,071
93,994
283,766
279,558
251,915
244,482
222,200
204,201
183,272
211,226
194,999
174,533
150,184
129,633
133,999
222,122
202,549
136,532
120,151
120,151136,532202,549222,122133,999129,633150,184174,533194,999211,226183,272204,201222,200244,482251,915279,558283,76693,99425,07125,44025,87723,34918,18918,58319,26520,04020,7209,69910,88910,66312,20414,07917,39019,07022,22024,74128,41331,69135,41337,50239,36740,82943,51045,30747,24350,10351,41652,84854,51856,50792,90794,03796,37198,489100,084101,964100,55798,484180,028181,260177,714178,471180,981184,255187,605190,636193,598177,105190,363205,374206,407206,659210,254207,114216,859211,693214,147214,16472,08781,68591,29399,65653,97461,03870,54078,75084,81642,62546,03651,24754,53058,38961,69365,71468,96371,96476,58579,77382,57620,07322,283
       Cash And Cash Equivalents 
22,179
20,021
81,997
78,927
75,953
71,642
68,442
65,274
61,359
57,806
53,893
50,091
45,664
42,546
46,900
12,027
7,181
3,172
1,750
1,379
107
2,512
1,421
95,651
67,825
51,109
31,558
16,386
61,816
49,191
40,814
86,567
130,807
125,425
143,950
153,158
172,790
145,200
29,169
35,794
50,657
66,773
106,292
4,798
54,894
62,830
71,709
73,144
73,779
79,020
88,240
56,254
51,591
51,545
51,027
49,838
47,102
44,825
42,052
40,590
39,248
36,352
33,993
31,299
26,614
24,626
21,764
18,714
17,264
14,067
11,916
10,479
10,734
9,608
20,444
19,807
19,125
18,534
17,804
23,081
25,600
25,254
24,074
93,506
282,192
278,254
241,524
233,437
209,693
197,232
174,662
201,015
187,467
168,438
142,350
121,136
124,169
207,291
148,978
128,574
117,328
117,328128,574148,978207,291124,169121,136142,350168,438187,467201,015174,662197,232209,693233,437241,524278,254282,19293,50624,07425,25425,60023,08117,80418,53419,12519,80720,4449,60810,73410,47911,91614,06717,26418,71421,76424,62626,61431,29933,99336,35239,24840,59042,05244,82547,10249,83851,02751,54551,59156,25488,24079,02073,77973,14471,70962,83054,8944,798106,29266,77350,65735,79429,169145,200172,790153,158143,950125,425130,80786,56740,81449,19161,81616,38631,55851,10967,82595,6511,4212,5121071,3791,7503,1727,18112,02746,90042,54645,66450,09153,89357,80661,35965,27468,44271,64275,95378,92781,99720,02122,179
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
36,290
55
63,004
57,820
51,809
98,018
0
79,138
70,126
117,001
141,963
154,232
182,360
188,014
148,144
157,136
165,113
118,504
59,245
51,648
49,240
36,937
12,784
37,017
148,306
139,965
124,876
109,469
73,450
86,428
43,583
38,211
27,651
24,987
22,117
14,922
4,289
6,899
2,800
1,300
1,300
1,250
1,250
250
1,100
0
1,999
950
900
0
1,500
0
550
2,099
2,099
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000002,0992,09955001,50009009501,99901,1002501,2501,2501,3001,3002,8006,8994,28914,92222,11724,98727,65138,21143,58386,42873,450109,469124,876139,965148,30637,01712,78436,93749,24051,64859,245118,504165,113157,136148,144188,014182,360154,232141,963117,00170,12679,138098,01851,80957,82063,0045536,29000000000000000
       Net Receivables 
32
6
8
445
355
255
200
117
96
83
74
55
46
38
0
65,402
65,402
0
-415
98,018
91,034
0
0
889
4,234
6,305
2,596
0
0
0
0
0
0
0
0
0
0
0
0
2,302
0
0
0
7,114
1,996
908
231
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
86
0
1,271
0
0
0
0
0
0
0
0
1,328
1,285
962
1,000
1,439
6,275
947
864
8649476,2751,4391,0009621,2851,328000000001,271086000000000000000000000000000000000002319081,9967,1140002,3020000000000002,5966,3054,2348890091,03498,018-415065,40265,40203846557483961172002553554458632
       Other Current Assets 
72
46
571
0
278
67
321
323
238
500
563
1,101
326
41
1,626
1,321
355
46
415
518
152
35
540
623
125
47
345
2,714
294
332
480
303
311
32
408
541
2,031
2,038
3,506
2,712
2,181
5,018
286
144
84
15
493
358
475
95
378
253
127
3
389
265
141
482
358
239
119
200
520
392
299
115
456
356
126
12
288
184
155
91
276
233
140
49
385
268
277
186
1,683
945
1,574
2,608
10,391
11,045
12,507
6,974
9,918
10,211
7,532
4,767
8,970
7,535
8,830
13,392
53,571
7,011
1,959
1,9597,01153,57113,3928,8307,5358,9704,7677,53210,2119,9186,97412,50711,04510,3912,6081,5749451,68318627726838549140233276911551842881212635645611529939252020011923935848214126538931272533789547535849315841442865,0182,1812,7123,5062,0382,031541408323113034803322942,7143454712562354035152518415463551,3211,626413261,1015635002383233216727805714672
   > Long-term Assets 
582
1,066
265
0
2,246
2,540
2,506
2,421
2,339
2,251
2,161
2,078
1,992
1,906
1,822
1,763
1,885
1,866
1,828
1,536
1,479
1,505
1,687
1,631
1,631
1,550
1,427
1,342
1,991
1,974
2,403
2,251
2,134
2,017
1,899
2,800
2,128
2,061
1,751
3,534
883
824
766
711
669
629
508
474
439
403
352
352
352
352
340
7,504
76
84
81
77
268
254
240
227
213
199
262
232
214
190
173
168
169
134
116
99
258
222
186
137
100
58
330
306
284
1,747
22,334
22,300
21,991
23,180
24,014
23,608
23,112
22,715
22,345
22,030
21,719
21,446
21,204
21,001
20,781
20,78121,00121,20421,44621,71922,03022,34522,71523,11223,60824,01423,18021,99122,30022,3341,7472843063305810013718622225899116134169168173190214232262199213227240254268778184767,5043403523523523524034394745086296697117668248833,5341,7512,0612,1282,8001,8992,0172,1342,2512,4031,9741,9911,3421,4271,5501,6311,6311,6871,5051,4791,5361,8281,8661,8851,7631,8221,9061,9922,0782,1612,2512,3392,4212,5062,5402,24602651,066582
       Property Plant Equipment 
122
124
265
1,299
2,171
2,465
2,431
2,346
2,264
2,176
2,086
2,003
1,917
1,831
1,747
1,688
1,810
1,791
1,753
1,461
1,404
1,430
1,612
1,556
1,556
1,475
1,352
1,267
1,223
1,206
1,549
1,607
1,490
1,373
1,256
774
708
641
578
517
457
398
340
285
232
192
157
122
87
52
352
0
0
0
0
0
76
72
69
100
256
242
228
200
201
187
250
300
214
190
173
200
139
122
104
100
246
210
174
137
100
58
330
306
284
327
20,926
20,826
21,051
22,321
23,274
22,986
22,609
22,328
22,077
21,854
21,604
21,364
21,135
20,964
20,781
20,78120,96421,13521,36421,60421,85422,07722,32822,60922,98623,27422,32121,05120,82620,926327284306330581001371742102461001041221392001731902143002501872012002282422561006972760000035252871221571922322853403984575175786417087741,2561,3731,4901,6071,5491,2061,2231,2671,3521,4751,5561,5561,6121,4301,4041,4611,7531,7911,8101,6881,7471,8311,9172,0032,0862,1762,2642,3462,4312,4652,1711,299265124122
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,209
1,075
940
859
740
622
503
387
268
176
115
82
69
37
0
03769821151762683875036227408599401,0751,20900000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Long-term Assets Other 
460
942
0
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
768
768
854
644
644
644
643
2,026
1,420
1,420
1,173
3,017
426
426
426
426
437
437
351
352
352
351
352
352
352
352
340
7,504
0
12
12
-23
12
12
12
27
12
12
12
-68
232
0
0
-32
30
12
12
-1
12
12
12
90
67
45
0
295
274
1,420
199
399
188
166
144
0
0
0
0
0
0
0
0
0
0
00000000001441661883991991,4202742950456790121212-1121230-3200232-6812121227121212-23121207,5043403523523523523513523523514374374264264264263,0171,1731,4201,4202,026643644644644854768768757575757575757575757575757575757575757575757575750942460
> Total Liabilities 
488
720
1,352
2,452
2,600
1,487
1,386
2,519
1,993
2,003
1,460
3,101
2,319
2,395
4,018
3,951
5,820
5,161
7,127
7,796
8,221
8,253
7,635
152,435
149,498
144,191
136,950
130,541
121,120
115,122
109,762
103,711
100,174
95,735
92,983
89,150
85,557
80,463
76,671
73,753
68,647
71,398
69,603
66,262
62,829
59,562
57,106
54,570
51,512
48,271
46,927
43,723
41,460
39,025
37,504
1,801
1,618
1,739
2,383
850
1,200
1,813
2,586
2,551
3,344
1,953
2,167
665
883
999
1,010
1,132
758
1,287
862
511
970
982
930
1,387
1,145
1,314
1,426
2,100
2,863
4,825
6,684
12,867
7,097
9,011
8,567
7,295
14,106
17,895
17,414
14,195
77,121
54,594
57,114
11,829
13,316
13,31611,82957,11454,59477,12114,19517,41417,89514,1067,2958,5679,0117,09712,8676,6844,8252,8632,1001,4261,3141,1451,3879309829705118621,2877581,1321,0109998836652,1671,9533,3442,5512,5861,8131,2008502,3831,7391,6181,80137,50439,02541,46043,72346,92748,27151,51254,57057,10659,56262,82966,26269,60371,39868,64773,75376,67180,46385,55789,15092,98395,735100,174103,711109,762115,122121,120130,541136,950144,191149,498152,4357,6358,2538,2217,7967,1275,1615,8203,9514,0182,3952,3193,1011,4602,0031,9932,5191,3861,4872,6002,4521,352720488
   > Total Current Liabilities 
488
720
1,352
2,452
2,600
1,487
1,386
2,519
1,993
2,003
1,460
3,101
2,319
2,395
4,018
3,951
5,820
5,161
7,127
7,796
8,221
8,253
7,635
32,347
35,960
37,203
36,512
36,654
33,023
33,575
34,762
20,657
20,706
19,854
20,683
20,114
19,577
18,069
18,110
18,511
12,692
13,760
14,689
14,071
13,361
12,818
13,085
13,272
12,938
12,421
13,800
9,999
9,694
9,218
9,655
1,801
1,618
1,739
2,383
850
1,200
1,813
2,586
2,551
3,344
1,953
2,167
665
883
999
1,010
1,132
758
1,287
862
511
902
937
907
1,387
1,145
1,314
1,168
1,865
2,650
4,637
6,326
12,534
6,789
8,722
8,308
7,063
13,909
17,895
17,414
14,195
77,121
54,594
57,034
11,750
13,237
13,23711,75057,03454,59477,12114,19517,41417,89513,9097,0638,3088,7226,78912,5346,3264,6372,6501,8651,1681,3141,1451,3879079379025118621,2877581,1321,0109998836652,1671,9533,3442,5512,5861,8131,2008502,3831,7391,6181,8019,6559,2189,6949,99913,80012,42112,93813,27213,08512,81813,36114,07114,68913,76012,69218,51118,11018,06919,57720,11420,68319,85420,70620,65734,76233,57533,02336,65436,51237,20335,96032,3477,6358,2538,2217,7967,1275,1615,8203,9514,0182,3952,3193,1011,4602,0031,9932,5191,3861,4872,6002,4521,352720488
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,295
6,690
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,820
0
0
576
0
0
0
0
793
929
0
0
742
41,760
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
180
180
180
180
134
90
116
116
168
186
190
97
99
200
204
104
0
0
0
0
0
0
0
0
0
0000000001042042009997190186168116116901341801801801800000000000000000000041,760742009297930000576007,820000000000000006,6906,29500000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
90
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000900000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
488
720
1,352
0
2,405
1,343
1,231
2,170
1,446
1,406
1,072
2,648
1,728
1,731
3,537
3,441
5,105
817
831
877
904
1,006
564
998
820
596
438
985
840
2,220
3,008
3,624
2,962
3,206
3,485
2,216
1,685
975
1,005
1,317
485
625
715
1,107
436
604
556
464
502
501
507
1,290
366
435
1,273
1,086
428
360
822
173
255
465
898
1,034
1,043
378
1,083
303
573
658
712
424
421
962
549
294
495
594
340
453
608
416
465
911
864
1,912
2,345
7,126
3,332
4,758
3,534
4,017
8,242
10,338
9,492
10,573
9,603
52,552
52,244
7,654
8,192
8,1927,65452,24452,5529,60310,5739,49210,3388,2424,0173,5344,7583,3327,1262,3451,9128649114654166084533405944952945499624214247126585733031,0833781,0431,0348984652551738223604281,0861,2734353661,2905075015024645566044361,1077156254851,3171,0059751,6852,2163,4853,2062,9623,6243,0082,2208409854385968209985641,0069048778318175,1053,4413,5371,7311,7282,6481,0721,4061,4462,1701,2311,3432,40501,352720488
       Other Current Liabilities 
0
0
0
0
195
144
155
349
547
597
388
453
591
664
481
510
715
4,344
6,296
6,919
7,317
7,247
7,071
5,149
8,940
6,050
6,295
6,690
5,983
5,155
5,554
2,685
3,396
2,300
2,850
3,550
3,544
2,746
2,757
2,846
2,110
2,238
10,897
2,067
2,028
1,317
1,632
1,911
1,539
1,023
2,396
1,806
1,496
951
1,292
1,356
1,190
1,379
1,561
-30,794
945
1,348
1,688
13,903
2,301
1,575
1,084
14,507
310
341
298
708
337
325
313
217
227
163
387
754
403
808
587
838
1,618
2,539
3,791
5,311
3,358
3,764
4,570
2,942
5,667
7,557
7,922
3,622
67,518
2,042
4,790
5,179
5,045
5,0455,1794,7902,04267,5183,6227,9227,5575,6672,9424,5703,7643,3585,3113,7912,5391,61883858780840375438716322721731332533770829834131014,5071,0841,5752,30113,9031,6881,348945-30,7941,5611,3791,1901,3561,2929511,4961,8062,3961,0231,5391,9111,6321,3172,0282,06710,8972,2382,1102,8462,7572,7463,5443,5502,8502,3003,3962,6855,5545,1555,9836,6906,2956,0508,9405,1497,0717,2477,3176,9196,2964,3447155104816645914533885975473491551441950000
   > Long-term Liabilities 
488
720
1,352
0
2,405
1,343
1,231
2,170
1,446
1,406
1,072
2,648
1,728
1,731
3,537
3,441
5,105
817
831
877
904
1,006
564
120,088
113,538
106,988
100,438
93,887
88,097
81,547
75,000
83,054
79,468
75,881
72,300
69,036
65,980
62,394
58,561
55,242
55,955
57,638
54,914
52,191
49,468
46,744
44,021
41,298
38,574
35,850
33,127
33,724
31,766
29,807
27,849
445
428
360
822
173
255
465
898
1,034
1,043
378
1,083
303
573
658
712
424
421
962
549
294
68
45
23
543
675
461
258
235
213
188
358
333
308
289
259
232
197
0
0
0
0
0
80
79
79
797980000001972322592893083333581882132352584616755432345682945499624214247126585733031,0833781,0431,03489846525517382236042844527,84929,80731,76633,72433,12735,85038,57441,29844,02146,74449,46852,19154,91457,63855,95555,24258,56162,39465,98069,03672,30075,88179,46883,05475,00081,54788,09793,887100,438106,988113,538120,0885641,0069048778318175,1053,4413,5371,7311,7282,6481,0721,4061,4462,1701,2311,3432,40501,352720488
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
194
194
194
201
197
197
0
0
0
0
0
0
0
0
0
00000000019719720119419419400000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
46,312
43,587
41,298
38,574
35,850
33,127
33,724
31,766
29,807
27,849
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000000000027,84929,80731,76633,72433,12735,85038,57441,29843,58746,312000000000000000000000000000000000000000000000
> Total Stockholder Equity
22,377
20,418
81,489
0
76,231
73,017
70,084
65,616
62,038
58,636
55,231
50,224
45,709
42,136
82,620
76,562
66,605
57,743
48,675
93,396
84,551
74,937
66,139
63,360
66,280
69,052
81,336
77,915
91,125
93,511
99,048
103,914
92,323
83,387
102,514
104,286
104,176
105,853
106,061
108,252
109,950
110,686
111,191
32,933
38,397
43,031
43,486
44,393
45,298
46,169
46,332
13,136
13,410
14,175
14,252
48,302
45,701
43,652
41,208
40,056
38,435
35,943
33,067
29,367
25,282
22,987
20,315
18,637
16,721
13,270
11,367
9,699
10,300
8,546
19,974
19,628
18,553
17,823
17,445
22,099
24,832
24,184
23,973
92,200
281,187
276,480
267,565
253,915
237,094
218,370
198,719
227,539
204,005
179,353
155,115
137,468
78,597
188,974
166,639
145,704
127,616
127,616145,704166,639188,97478,597137,468155,115179,353204,005227,539198,719218,370237,094253,915267,565276,480281,18792,20023,97324,18424,83222,09917,44517,82318,55319,62819,9748,54610,3009,69911,36713,27016,72118,63720,31522,98725,28229,36733,06735,94338,43540,05641,20843,65245,70148,30214,25214,17513,41013,13646,33246,16945,29844,39343,48643,03138,39732,933111,191110,686109,950108,252106,061105,853104,176104,286102,51483,38792,323103,91499,04893,51191,12577,91581,33669,05266,28063,36066,13974,93784,55193,39648,67557,74366,60576,56282,62042,13645,70950,22455,23158,63662,03865,61670,08473,01776,231081,48920,41822,377
   Common Stock
10
10
27
0
27
27
27
27
27
27
27
27
27
27
35
35
35
36
36
44
44
44
44
44
44
44
44
44
44
44
44
44
42
41
42
42
42
42
42
42
43
43
43
43
44
45
45
45
45
45
45
45
45
45
151,373
45
153,257
154,454
45
46
157,510
46
46
46
46
162,435
163,280
46
46
7
7
7
7
7
17
17
183,868
17
17
190,686
25
25
26
267,121
459,634
460,052
460,699
461,221
40
462,531
463,137
511,091
511,828
513,552
514,965
42
43
48
48
48
48
484848484342514,965513,552511,828511,091463,137462,53140461,221460,699460,052459,634267,121262525190,6861717183,8681717777774646163,280162,43546464646157,5104645154,454153,25745151,37345454545454545454544434343434242424242424142444444444444444444444444443636353535272727272727272727270271010
   Retained Earnings Total Equity0000000-334,199-307,8230-264,418-244,161-224,833-207,306-193,134-183,572-178,447-174,9210-170,873-169,737-168,587-167,071-166,374-165,315-163,956-163,279-162,012-159,559-157,399-154,982-152,391-148,231-145,488-142,966-139,448-136,433-130,638-126,121-122,450-119,076-116,493-114,337-110,802-107,557-104,107-137,122-136,360-136,059-135,651-133,857-132,306-132,175-132,205-131,814-130,999000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
-8,572
-7,099
-6,914
-49
-3,768
-2,893
-2,406
-1,914
-1,480
-1,279
-1,388
-426
-318
-68
-1
43
157
-267
-122
-544
-823
-472
-512
-479
-815
-1,130
-291
-372
103
-177
354
584
905
465
-183
325
195
99
-31
347
664
473
693
525
468
394
121
128
96
43
2
4
1
1
1
1
1
0
1
1
1
1
1
-700
0
0
1
-700
-700
0
0
-800
0
0
0
-900
-900
0
0
-900
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000-90000-900-900000-80000-700-700100-70011111011111424396128121394468525693473664347-3199195325-183465905584354-177103-372-291-1,130-815-479-512-472-823-544-122-26715743-1-68-318-426-1,388-1,279-1,480-1,914-2,406-2,893-3,768-49-6,914-7,099-8,572
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
173,591
175,134
176,425
177,332
178,387
180,142
148,738
149,423
150,489
151,328
152,363
153,212
154,409
155,499
156,502
157,464
158,346
159,141
159,959
161,669
162,389
163,234
164,079
164,906
165,654
166,342
167,091
169,852
170,551
183,236
183,567
183,851
184,180
184,499
190,664
194,544
195,032
0
267,086
459,594
460,012
460,659
461,181
461,887
462,491
463,097
0
511,786
513,510
0
0
0
0
0
0
0
0000000513,510511,7860463,097462,491461,887461,181460,659460,012459,594267,0860195,032194,544190,664184,499184,180183,851183,567183,236170,551169,852167,091166,342165,654164,906164,079163,234162,389161,669159,959159,141158,346157,464156,502155,499154,409153,212152,363151,328150,489149,423148,738180,142178,387177,332176,425175,134173,591000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
17,698
17,780
107,857
0
104,533
103,529
103,478
104,209
104,223
104,334
104,088
103,254
103,248
103,770
150,149
150,732
150,824
151,452
151,469
205,920
205,943
206,160
206,168
206,489
208,868
210,588
212,378
214,749
215,595
216,077
217,910
221,415
214,238
210,785
215,369
218,021
219,865
221,672
223,322
225,432
227,832
229,563
230,569
161,957
167,684
173,591
175,134
176,425
177,332
178,387
180,142
148,738
149,423
150,489
151,328
152,363
153,212
154,409
155,499
156,502
157,464
158,346
159,141
159,959
161,669
162,389
163,234
164,079
164,906
165,654
166,342
167,091
169,852
170,551
183,236
183,567
183,851
184,180
184,499
190,664
194,544
195,032
196,250
267,086
459,594
460,012
460,659
461,181
461,887
462,491
463,097
511,049
511,786
513,510
514,923
518,195
434,280
538,497
544,105
550,767
556,082
556,082550,767544,105538,497434,280518,195514,923513,510511,786511,049463,097462,491461,887461,181460,659460,012459,594267,086196,250195,032194,544190,664184,499184,180183,851183,567183,236170,551169,852167,091166,342165,654164,906164,079163,234162,389161,669159,959159,141158,346157,464156,502155,499154,409153,212152,363151,328150,489149,423148,738180,142178,387177,332176,425175,134173,591167,684161,957230,569229,563227,832225,432223,322221,672219,865218,021215,369210,785214,238221,415217,910216,077215,595214,749212,378210,588208,868206,489206,168206,160205,943205,920151,469151,452150,824150,732150,149103,770103,248103,254104,088104,334104,223104,209103,478103,529104,5330107,85717,78017,698



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-141,446
Operating Income-142,278-141,446
 
Operating Expense (+$)
Research Development69,637
Selling General Administrative71,809
Selling And Marketing Expenses0
Operating Expense141,446141,446
 
Net Interest Income (+$)
Interest Income8,510
Interest Expense-0
Other Finance Cost-0
Net Interest Income8,510
 
Pretax Income (+$)
Operating Income-142,278
Net Interest Income8,510
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-24,342-251,705
EBIT - interestExpense = -24,342
-24,342
-24,342
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-24,342-24,342
Earnings Before Interest and Taxes (EBITDA)-23,210
 
After tax Income (+$)
Income Before Tax-24,342
Tax Provision-0
Net Income From Continuing Ops-24,342-24,342
Net Income-24,342
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net109,427-8,510
 

Technical Analysis of Cassava Sciences Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Cassava Sciences Inc. The general trend of Cassava Sciences Inc is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Cassava Sciences Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Cassava Sciences Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Cassava Sciences Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 2.23 < 2.25 < 2.27.

The bearish price targets are: 1.75 > 1.73 > 1.45.

Know someone who trades $SAVA? Share this with them.👇

Cassava Sciences Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Cassava Sciences Inc. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Cassava Sciences Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Cassava Sciences Inc. The current macd is 0.02948317.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Cassava Sciences Inc price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Cassava Sciences Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Cassava Sciences Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Cassava Sciences Inc Daily Moving Average Convergence/Divergence (MACD) ChartCassava Sciences Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Cassava Sciences Inc. The current adx is 18.33.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Cassava Sciences Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Cassava Sciences Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Cassava Sciences Inc. The current sar is 1.82867312.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Cassava Sciences Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Cassava Sciences Inc. The current rsi is 57.56. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending down: The RSI is trending down. -1
Cassava Sciences Inc Daily Relative Strength Index (RSI) ChartCassava Sciences Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Cassava Sciences Inc. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Cassava Sciences Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Cassava Sciences Inc Daily Stochastic Oscillator ChartCassava Sciences Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Cassava Sciences Inc. The current cci is 94.99.

Cassava Sciences Inc Daily Commodity Channel Index (CCI) ChartCassava Sciences Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Cassava Sciences Inc. The current cmo is 20.68.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Cassava Sciences Inc Daily Chande Momentum Oscillator (CMO) ChartCassava Sciences Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Cassava Sciences Inc. The current willr is -20.83333333.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Cassava Sciences Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Cassava Sciences Inc Daily Williams %R ChartCassava Sciences Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Cassava Sciences Inc.

Cassava Sciences Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Cassava Sciences Inc. The current atr is 0.11550011.

Cassava Sciences Inc Daily Average True Range (ATR) ChartCassava Sciences Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Cassava Sciences Inc. The current obv is -214,914,830.

Cassava Sciences Inc Daily On-Balance Volume (OBV) ChartCassava Sciences Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Cassava Sciences Inc. The current mfi is 35.89.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Cassava Sciences Inc Daily Money Flow Index (MFI) ChartCassava Sciences Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Cassava Sciences Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-02-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-02-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-03-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-18STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-07MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-04-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-04-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-04-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-05-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-12BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-05-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-15STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-19MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-20STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-21RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-06-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-06-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-06-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-06-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-06-27MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-30STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-07-01MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-07-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-07-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-07-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-11STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Cassava Sciences Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Cassava Sciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5057.564
Ma 20Greater thanMa 501.989
Ma 50Greater thanMa 1001.969
Ma 100Greater thanMa 2002.016
OpenGreater thanClose2.150
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Cassava Sciences Inc with someone you think should read this too:
  • Are you bullish or bearish on Cassava Sciences Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Cassava Sciences Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Cassava Sciences Inc

I send you an email if I find something interesting about Cassava Sciences Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Cassava Sciences Inc.

Receive notifications about Cassava Sciences Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.